- Home
- FLYE vs ERNA Comparison
FLYE vs ERNA Comparison
Compare FLYE & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYE
- ERNA
- Stock Information
- Founded
- FLYE 2018
- ERNA 2018
- Country
- FLYE United States
- ERNA United States
- Employees
- FLYE N/A
- ERNA N/A
- Industry
- FLYE Aerospace
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- FLYE Industrials
- ERNA Health Care
- Exchange
- FLYE Nasdaq
- ERNA Nasdaq
- Market Cap
- FLYE 16.9M
- ERNA 15.8M
- IPO Year
- FLYE 2024
- ERNA N/A
- Fundamental
- Price
- FLYE $0.46
- ERNA $0.31
- Analyst Decision
- FLYE
- ERNA
- Analyst Count
- FLYE 0
- ERNA 0
- Target Price
- FLYE N/A
- ERNA N/A
- AVG Volume (30 Days)
- FLYE 957.4K
- ERNA 662.5K
- Earning Date
- FLYE 02-19-2025
- ERNA 03-13-2025
- Dividend Yield
- FLYE N/A
- ERNA N/A
- EPS Growth
- FLYE N/A
- ERNA N/A
- EPS
- FLYE N/A
- ERNA N/A
- Revenue
- FLYE $28,547,111.00
- ERNA $598,000.00
- Revenue This Year
- FLYE N/A
- ERNA N/A
- Revenue Next Year
- FLYE N/A
- ERNA N/A
- P/E Ratio
- FLYE N/A
- ERNA N/A
- Revenue Growth
- FLYE N/A
- ERNA 1072.55
- 52 Week Low
- FLYE $0.38
- ERNA $0.22
- 52 Week High
- FLYE $7.62
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- FLYE N/A
- ERNA 44.59
- Support Level
- FLYE N/A
- ERNA $0.25
- Resistance Level
- FLYE N/A
- ERNA $0.37
- Average True Range (ATR)
- FLYE 0.00
- ERNA 0.04
- MACD
- FLYE 0.00
- ERNA -0.00
- Stochastic Oscillator
- FLYE 0.00
- ERNA 54.08
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.